Antoine Vallatos

Antoine Vallatos

Auto-generated profile, based on publicly available information

Antoine Vallatos

Edinburgh Neuro-Oncology Translational Imaging Research (ENTIRe), Institute for Neuroscience and Cardiovascular Research, University of Edinburgh , Edinburgh

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JBJoanna L. Birch
Joanna L. Birch
KSKaren Strathdee
Karen Strathdee
LGLesley Gilmour
Lesley Gilmour
AVAntoine Vallatos
Antoine Vallatos
LMLaura McDonald
Laura McDonald
ACAnthony Chalmers
Anthony Chalmers
Glioblastoma (GBM) is an aggressive and incurable primary brain tumor that causes severe neurologic, cognitive, and psychologic symptoms. Symptoms are caused and exacerbated by the infiltrative properties of GBM cells, which enable them to pervade the healthy brain and disrupt normal function. Recent research has indicated that although radiotherapy (RT) remains the most effective component of multimodality therapy for patients with GBM, it can provoke a more infiltrative phenotype in GBM cells that survive treatment. Here, we demonstrate an essential role of the actin-myosin regulatory kinase myotonic dystrophy kinase-related CDC42-binding kinase (MRCK) in mediating the proinvasive effects of radiation. MRCK-mediated invasion occurred via downstream signaling to effector molecules MYPT1 and MLC2. MRCK was activated by clinically relevant doses per fraction of radiation, and this activation was concomitant with an increase in GBM cell motility and invasion. Furthermore, ablation of MRCK activity either by RNAi or by inhibition with the novel small-molecule inhibitor BDP-9066 prevented radiation-driven increases in motility both in vitro and in a clinically relevant orthotopic xenograft model of GBM. Crucially, treatment with BDP-9066 in combination with RT significantly increased survival in this model and markedly reduced infiltration of the contralateral cerebral hemisphere. Significance: An effective new strategy for the treatment of glioblastoma uses a novel, anti-invasive chemotherapeutic to prevent infiltration of the normal brain by glioblastoma cells.Cancer Res; 78(22); 6509–22. ©2018 AACR.

28 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MAM. M. C. Arroja
M. M. C. Arroja
ERE. Reid
E. Reid
LRL. A. Roy
L. A. Roy
AVA. V. Vallatos
A. V. Vallatos
WHW. M. Holmes
W. M. Holmes
CMC. McCabe
C. McCabe
The counter-regulatory axis, Angiotensin Converting Enzyme 2, Angiotensin-(1-7), Mas receptor (ACE2/Ang-1-7/MasR), of the renin angiotensin system (RAS) is a potential therapeutic target in stroke, with Ang-(1-7) reported to have neuroprotective effects in pre-clinical stroke models. Here, an extensive investigation of the functional and mechanistic effects of Ang-(1-7) was performed in a rodent model of stroke. Using longitudinal magnetic resonance imaging (MRI) it was observed that central administration of Ang-(1-7) following transient middle cerebral artery occlusion (MCAO) increased the amount of tissue salvage compared to reperfusion alone. This protective effect was not due to early changes in blood brain barrier (BBB) permeability, microglia activation or inflammatory gene expression. However, increases in NADPH oxidase 1 (Nox1) mRNA expression were observed in the treatment group compared to control. In order to determine whether Ang-(1-7) has direct cerebrovascular effects, laser speckle contrast imaging (LSCI) was performed to measure dynamic changes in cortical perfusion following reperfusion. Delivery of Ang-(1-7) did not have any effect on cortical perfusion following reperfusion however; it showed an indication to prevent the ‘steal phenomenon’ within the contralateral hemisphere. The comprehensive series of studies have demonstrated a moderate protective effect of Ang-(1-7) when given alongside reperfusion to increase tissue salvage.

17 May 2017 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
AVAntoine Vallatos
Antoine Vallatos
LGLesley Gilmour
Lesley Gilmour
ACAnthony J. Chalmers
Anthony J. Chalmers
WHWilliam M. Holmes
William M. Holmes

13 January 2026 in Cerebral Circulation - Cognition and Behavior
Verified
Journal Article
Open access
MSMichael S Stringer
Michael S Stringer
XSXingfeng Shao
Xingfeng Shao
HLHedok Lee
Hedok Lee
AVAntoine Vallatos
Antoine Vallatos
CACarmen Arteaga-Reyes
Carmen Arteaga-Reyes
JWJoanna M Wardlaw
Joanna M Wardlaw
Subtle blood-brain barrier (BBB) leakage has been detected in small vessel disease (SVD). While established methods rely on gadolinium-based contrast agents (GBCA), diffusion-weighted arterial spin labelling (DW-ASL) is a promising alternative which assesses water exchange rate (kw) without injected contrast. However, DW-ASL has not been widely applied in sporadic SVD. We aimed to determine how kw varied with GBCA BBB leakage measures, baseline and 1-year change in SVD burden. We recruited patients with mild ischaemic stroke (lacunar or cortical) all characterised for SVD features. We assessed kw using DW-ASL and GBCA measures of BBB leakage (permeability-surface area product (PS), blood plasma volume and exchange rate of GBCA) using dynamic-contrast enhanced MRI. We used separate linear regression models to assess how kw varied with GBCA-derived metrics, baseline and 1-year change in WMH volume in co-variate-adjusted analyses. We included 24 with complete MRI (61±10 years; 71% male). Patients with higher kw tended to have more severe baseline SVD (e.g. subcortical grey matter (SGM): B=14.59 min-1/%WMH volume, 95% confidence interval (95%CI)=-1.00,28.18, p=0.04) and greater 1-year increase (B=0.0013 %WMH volume increase/min-1, 95%CI=-0.0001, 0.0026, p=0.06). We generally found kw and GBCA BBB leakage measures were not meaningfully associated (e.g. SGM kw∼PS: B=-0.23 min-1/10-4 min-1, 95%CI=-7.47, 7.01, p=0.95). BBB water exchange estimated using DW-ASL tended to be greater with higher WMH burden and progression, suggesting kw may be a sensitive measure of BBB dysfunction in SVD. However, non-concordance between kw and GBCA metrics suggests the two methods probe different aspects of BBB function.

16 June 2025 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
MSM. Sulaiman Sarwar
M. Sulaiman Sarwar
AVAntoine Vallatos
Antoine Vallatos
CLCher Hon Lau
Cher Hon Lau
AWAdam Waldman
Adam Waldman
SDSimone Dimartino
Simone Dimartino
MTMichael J Thrippleton
Michael J Thrippleton
Purpose: A novel 3D‐printed phantom design and methodology are proposed, addressing important requirements for technical validation, quality assurance, and multi‐site harmonization of quantitative DCE‐MRI measurements.Methods: Phantoms were produced by 3D‐printing (3DP) gels incorporating channels and pores as proxies for blood vessels and extravascular extracellular space, respectively. A flow circuit was designed to reproduce clinically relevant arterial input functions. Using nine gels with variable porosity and channel size, we evaluated the effect of 3DP parameters on DCE‐MRI parameters obtained using the extended Tofts model (ET). Physical gel and fitted model parameters were correlated by multiple linear regression.Results: All phantoms generated realistic arterial input functions, and tissue‐like signal enhancement curves were accurately modeled by the ET model. As hypothesized, blood plasma volume fraction, vp, was positively associated with the channel volume fraction, vchan, (B = 0.86, p < 0.001) and showed a weaker, negative association with gel porosity, vpore, (B = −0.18, p = 0.006). Vascular permeability‐surface area product, PS, was positively associated with both vchan (B = 0.13 min−1, p < 0.001); and vpore (B = 0.051 min−1, p < 0.001). The extravascular extracellular space (EES) volume fraction, ve, was positively associated with vpore (B = 0.90, p < 0.001) but not vchan. Fitted parameters were reproducible (coefficient of variation 2.1%–3.2%).Conclusions: Tailorable 3D‐printed porous gel phantoms generating tissue‐mimicking DCE‐MRI signals have the potential to support validation, quality assurance, and multi‐site harmonization of quantitative DCE‐MRI.

31 March 2023
Verified
Other
Open access
JBJoanna L. Birch
Joanna L. Birch
KSKaren Strathdee
Karen Strathdee
LGLesley Gilmour
Lesley Gilmour
AVAntoine Vallatos
Antoine Vallatos
LMLaura McDonald
Laura McDonald
ACAnthony Chalmers
Anthony Chalmers
Glioblastoma (GBM) is an aggressive and incurable primary brain tumor that causes severe neurologic, cognitive, and psychologic symptoms. Symptoms are caused and exacerbated by the infiltrative properties of GBM cells, which enable them to pervade the healthy brain and disrupt normal function. Recent research has indicated that although radiotherapy (RT) remains the most effective component of multimodality therapy for patients with GBM, it can provoke a more infiltrative phenotype in GBM cells that survive treatment. Here, we demonstrate an essential role of the actin-myosin regulatory kinase myotonic dystrophy kinase-related CDC42-binding kinase (MRCK) in mediating the proinvasive effects of radiation. MRCK-mediated invasion occurred via downstream signaling to effector molecules MYPT1 and MLC2. MRCK was activated by clinically relevant doses per fraction of radiation, and this activation was concomitant with an increase in GBM cell motility and invasion. Furthermore, ablation of MRCK activity either by RNAi or by inhibition with the novel small-molecule inhibitor BDP-9066 prevented radiation-driven increases in motility both in vitro and in a clinically relevant orthotopic xenograft model of GBM. Crucially, treatment with BDP-9066 in combination with RT significantly increased survival in this model and markedly reduced infiltration of the contralateral cerebral hemisphere.Significance: An effective new strategy for the treatment of glioblastoma uses a novel, anti-invasive chemotherapeutic to prevent infiltration of the normal brain by glioblastoma cells.Cancer Res; 78(22); 6509–22. ©2018 AACR.